海量图书期刊资源,随时随地畅享阅读乐趣
Adalimumab, Etanercept, Infliximab, and the Risk of Tuberculosis: Data from Clinical Trials, National Registries, and Postmarketing SurveillanceCantini, F.; Niccoli, L.; Goletti, D. · The Journal of Rheumatology Supplement · 2014
Pathogenetic Overview of Psoriatic DiseaseHAROON, M.; FITZGERALD, O. · The Journal of Rheumatology Supplement · 2012
Differential Diagnosis of PsoriasisBALATO, N.; DI COSTANZO, L.; BALATO, A. · The Journal of Rheumatology Supplement · 2009
Retinoids and Phototherapy for PsoriasisMONFRECOLA, G.; BALDO, A. · The Journal of Rheumatology Supplement · 2009
Remission in Psoriatic ArthritisCAPERON, A.; HELLIWELL, P. S. · The Journal of Rheumatology Supplement · 2012
Early Psoriatic ArthritisSCARPA, R.; ATTENO, M.; COSTA, L.; PELUSO, R.; IERVOLINO, S.; CASO, F.; PUENTE, A. D. · The Journal of Rheumatology Supplement · 2009
Tuberculosis Reactivation Risk in DermatologyPescitelli, L.; Ricceri, F.; Prignano, F. · The Journal of Rheumatology Supplement · 2014
Infliximab in Psoriatic ArthritisCANTINI, F.; NICCOLI, L.; NANNINI, C.; KALOUDI, O.; CASSARA, E. · The Journal of Rheumatology Supplement · 2012
Etanercept in Psoriatic ArthritisSPADARO, A.; LUBRANO, E.; FERRARA, N.; SCARPA, R. · The Journal of Rheumatology Supplement · 2012